Nova análise mostra que os benefícios de se aplicar 2 doses de vacina contra COVID-19 em crianças de 12 a 17 anos supera os riscos.

Comunicado de imprensa: New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks – The Royal Society of Medicine

Relatório original: Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis

Contéudo relacionado: Covid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors.